GGrantIndex
Sort

39,280 grants matching leukemia

Cancer and Leukemia Group B Human Specimen Repositories

$1,014,550
Monica M Bertagnolli · Brigham And Women'S Hospital · U24 · FY2014 · CA

Development of humanized models using human induced pluripotent stem cells

$1,014,499
Elizabeth C Bryda · University Of Missouri-Columbia · RC2 · FY2010 · HL

Keratinocyte Stem Cells and Cancer Stem Cells in Non-Melanoma Skin Cancer

$1,014,494
Jonathan Vogel · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

A phase II dose expansion clinical trial testing the efficacy of CD24Fc for the prophylaxis of severe graft vs host disease and leukemia relapse

$1,014,321
Pan Zheng · Oncoimmune, Inc. · R44 · FY2019 · CA

IL-2 Family Cytokines and their Receptors-- Molecular Regulation via STATs

$1,013,999
Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2010 · HL

Macaque and human models for preclinical development of iPSCs

$1,013,860
Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL

Data Scientific Research

$1,013,769
David H Haussler · University Of California Santa Cruz · U54 · FY2017 · HG

Dual-targeting allogeneic CAR T-cells for universal therapy of T-cell malignancies

$1,013,623
Sarah Marie Hein · March Biosciences Inc · R44 · FY2024 · CA

Oncogenic Notch Signaling

$1,013,309
Jon C Aster · Brigham And Women'S Hospital · P01 · FY2016 · CA

Oncogenic Notch Signaling

$1,013,309
Jon C Aster · Brigham And Women'S Hospital · P01 · FY2015 · CA

Targeting Pediatric Cancer Vulnerabilities

$1,012,869
Kimberly Stegmaier · Dana-Farber Cancer Inst · R35 · FY2024 · CA

Targeting Tumor Suppressive Pathways for Cancer Therapy

$1,012,680
Pier Paolo Pandolfi · Beth Israel Deaconess Medical Center · R35 · FY2019 · CA

Oncogenic NOTCH Signaling

$1,012,243
Jon C Aster · Brigham And Women'S Hospital · P01 · FY2009 · CA

MOLECULAR PATHOGENESIS OF CHROMOSOME 16 INVERSION INHUMAN LEUKEMIA

$1,011,818
Pu Paul Liu · National Human Genome Research Institute · Z01 · FY2008 · HG

Non-Clinical Pharmacology of CX-01

$1,011,743
Galina Vid · Ceramedix Holding, Llc · R44 · FY2023 · AI

Targeting MicroRNAs to Eradicate Leukemia Stem Cells

$1,011,514
Ya-Huei Kuo · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA

Role of 11q23 Chromosome Abnormalities in the Causation of Acute Leukemia

$1,011,385
Carlo M Croce · Ohio State University · P01 · FY2009 · CA

Mechanisms of regulation by RNA in acute myeloid leukemia

$1,010,917
Daniel G Tenen · Beth Israel Deaconess Medical Center · R35 · FY2019 · CA

Flow Cytometric Analysis of Benign and Malignant Tumors

$1,010,633
Maryalice Stetler-Stevenson · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA

GENETIC ANALYSIS OF ZEBRAFISH EMBRYO DEVELOPMENT

$1,010,280
Pu Paul Liu · Human Genome Research · Z01 · FY2007 · HG

Stem Cell Biology, Cancer Stem Cell Biology, and Cancer Immunotherapy

$1,010,214
Irving Lerner Weissman · Stanford University · R35 · FY2018 · CA

Center for Big Data in Translational Genomics

$1,010,185
David H Haussler · University Of California Santa Cruz · U54 · FY2018 · HG

Studies of Populations Exposed to Diagnostic Medical Radiation

$1,010,162
Amy Berrington De Gonzalez · Division Of Cancer Epidemiology And Genetics · ZIA · FY2018 · CA

The Role of Wnt Genes in Vertebrate Development and Cancer

$1,010,124
Terence Yamaguchi · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

In vivo hematopoiesis

$1,009,452
Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL